Application of remifentanil in patient-controlled intravenous analgesia for labor

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100052509

Enrollment

Unknown

Registered

2021-10-30

Start date

2021-11-01

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

labour analgesia

Interventions

observation group:Remifentanil PCA, 30-40 µg, locking time 2min

Eligibility

Sex/Gender

Female

Age

20 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. The cardiopulmonary function is normal; 2. The opening of the uterine orifice is up to 8cm, and the pregnant women who intend to have vaginal delivery.

Exclusion criteria

Exclusion criteria: 1. Maternal rejected.

Design outcomes

Primary

Measure	Time frame
visual anoalogue scale;	—

Countries

China

Contacts

Public ContactLi Zhitao

Peking University Shenzhen Hospital

lytow@qq.com86 15986636692

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026